By Frank Prenesti
Date: Tuesday 11 Oct 2022
(Sharecast News) - Shares in healthcare company PureTech fell on Tuesday as the company said it and US-based Nektar Therapeutics had ended merger talks only four days after they announced a potential tie up.
| Puretech Health confirms possible tie-up with Ne... | 07-Oct-2022 | ShareCast |
| Puretech Health confirms possible tie-up with Ne... | 07-Oct-2022 | ShareCast |
| Nektar has wider first-quarter loss on Exubera c... | 08-May-2008 | BayArea.com |
| Lilly Ends Effort to Develop an Inhaled Insulin ... | 08-Mar-2008 | New York Times |
| Nektar cuts 150 jobs; operations chief steps down | 13-Feb-2008 | BayArea.com |
| Business Digest | 24-May-2007 | BayArea.com |
| Business Digest | 23-May-2006 | BayArea.com |
| Did Pfizer's marketing fizzle? | 31-Aug-2007 | BayArea.com |
| U.S. Regulators Approve Insulin in Inhaled Form | 28-Jan-2006 | New York Times |
| FDA expected to OK inhaled form of insulin | 27-Jan-2006 | BayArea.com |
| Stocks Mostly Listless; Dow Edges Down | 14-Jan-2006 | LA Times |
| Hot Stocks to Watch for Friday, April 28, 2006: ... | 28-Apr-2006 | Marketwired |
| Currency | US Dollars |
| Share Price | $ 54.26 |
| Change Today | $ -1.76 |
| % Change | -3.14 % |
| 52 Week High | $64.93 |
| 52 Week Low | $7.36 |
| Volume | 326 |
| Shares Issued | 180.09m |
| Market Cap | $9,772m |
| RiskGrade | 333 |
| Strong Buy | 3 |
| Buy | 3 |
| Neutral | 1 |
| Sell | 1 |
| Strong Sell | 0 |
| Total | 8 |

You are here: research